Perel, Pablo

Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

Steyerberg, E. W., Moons, K. G. M., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., Riley, R. D., Hemingway, H., Altman, D. G., & for the PROGRESS Group (2013) · PLoS Medicine

Statistical Methods in EpidemiologyMeta-analysis and systematic reviews

Cited by 1,508

Periodontitis and cardiovascular diseases: Consensus report

Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology

Oral microbiology and periodontitis researchDental Research and COVID-19

Cited by 1,482

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

Iorio, A., Spencer, F. A., Falavigna, M., Alba, C., Lang, E., Burnand, B., McGinn, T., Hayden, J., Williams, K., Shea, B., et al. (2015) · BMJ

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 880

Comparison of Treatment Effects between Animal Experiments and Clinical Trials: Systematic Review

Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C., Sandercock, P., Macleod, M., Mignini, L. E., Jayaram, P., & Khan, K. S. (2007) · BMJ

Animal testing and alternativesAcute Ischemic Stroke Management

Cited by 827

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events: A Systematic Review and Meta-analysis

Holmes, M. V., Perel, P., Shah, T., Hingorani, A. D., & Casas, J. P. (2011) · JAMA

Antiplatelet Therapy and Cardiovascular DiseasesPharmacogenetics and Drug Metabolism

Cited by 472

Polypill strategy in secondary cardiovascular prevention

Castellano, J. M., Pocock, S. J., Bhatt, D. L., Quesada, A. J., Owen, R., Fernandez-Ortiz, A., Sanchez, P. L., Marin Ortuño, F., Vazquez Rodriguez, J. M., Domingo-Fernández, A., et al. (2022) · New England Journal of Medicine

Acute Myocardial Infarction ResearchAntiplatelet Therapy and Cardiovascular Diseases

Cited by 334

The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation

Sacco, R. L., Roth, G. A., Reddy, K. S., Arnett, D. K., Bonita, R., Gaziano, T. A., Heidenreich, P. A., Huffman, M. D., Mayosi, B. M., Mendis, S., et al. (2016) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 268

The science of clinical practice: disease diagnosis or patient prognosis? Evidence about “what is likely to happen” should shape clinical practice

Croft, P., Altman, D. G., Deeks, J. J., Dunn, K. M., Hay, A. D., Hemingway, H., LeResche, L., Peat, G., Perel, P., Petersen, S. E., et al. (2015) · BMC Medicine

Clinical Reasoning and Diagnostic SkillsMedicine, History, and Philosophy

Cited by 250

The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review

Maimaris, W., Paty, J., Perel, P., Legido-Quigley, H., Balabanova, D., Nieuwlaat, R., & Mckee, M. (2013) · PLoS Medicine

Blood Pressure and Hypertension StudiesHealthcare Systems and Reforms

Cited by 176

The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: A systematic review of randomised controlled trials

Palmer, M., Sutherland, J., Barnard, S., Wynne, A., Rezel, E., Doel, A., Grigsby-Duffy, L., Edwards, S., Russell, S., Hotopf, E., et al. (2018) · PLOS ONE

Mobile Health and mHealth ApplicationsSmoking Behavior and Cessation

Cited by 136

Roadmap to Achieve 25% Hypertension Control in Africa by 2025

Dzudie, A., Rayner, B., Ojji, D., Schutte, A. E., Twagirumukiza, M., Damasceno, A., Ba, S. A., Kane, A., Kramoh, E., Anzouan Kacou, J. B., et al. (2018) · Global Heart

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 119

Socioeconomic deprivation: an important, largely unrecognized risk factor in primary prevention of cardiovascular disease

Kimenai, D. M., Pirondini, L., Gregson, J., Prieto, D., Pocock, S. J., Perel, P., Hamilton, T., Welsh, P., Campbell, A., Porteous, D. J., et al. (2022) · Circulation

Health Promotion and Cardiovascular PreventionHealth disparities and outcomes

Cited by 76

Diabetes care in a complex humanitarian emergency setting: a qualitative evaluation

Murphy, A., Biringanine, M., Roberts, B., Stringer, B., Perel, P., & Jobanputra, K. (2017) · BMC Health Services Research

Diabetes Management and EducationHealth and Conflict Studies

Cited by 54

Evaluation of a community-based hypertension improvement program (ComHIP) in Ghana: data from a baseline survey

Lamptey, P., Laar, A., Adler, A. J., Dirks, R., Caldwell, A., Prieto-Merino, D., Aerts, A., Pearce, N., & Perel, P. (2017) · BMC Public Health

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 53

World Heart Federation Cholesterol Roadmap

Murphy, A., Faria-Neto, J. R., Al-Rasadi, K., Blom, D., Catapano, A., Cuevas, A., Lopez-Jimenez, F., Perel, P., Santos, R., Sniderman, A., et al. (2017) · Global Heart

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 43